Dean Ding

Metamark Laboratories, Inc. provides molecular diagnostics services. The company is headquartered in Cambridge, MA.

Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.

GE Healthcare Ventures (GE Healthcare) is a venture capital subsidiary of GE Healthcare Ltd. (United Kingdom). The firm is headquartered in Norwalk, Connecticut.

Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA.

Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA.

Part of Danaher Corp., Molecular Devices (UK) Ltd. is a British company that develops molecular devices for life science research, pharmaceutical and bio therapeutic development. The company is based in Wokingham, UK and was founded in 1993.

NanoView Biosciences, Inc. engages in research and development of non technology. It develops ExoView platform that provides critical information that will assist in the translation of extracellular vesicle research into the clinical and therapeutic environment. The company was founded by David Freedman and George G. Daaboul and is headquartered in Boston, MA.

Phenomenex, Inc. develops, manufactures, and distributes chromatography products for the separation, analysis and purification of pharmaceuticals, biopharmaceuticals, and chemicals. Its customers include the life sciences, environmental, chemical, and healthcare industries. The company was founded by Fasha Mahjoor in 1982 and is headquartered in Torrance, CA.

Fluke Corp. manufactures and distributes electronic test tools and software. The firm's products include test tools, accessories, battery analyzers, bench instruments, clamp meters, data acquisition, digital millimeters, earth ground, electrical testers, fluke calibration, and fluke connect. The company was founded in 1948 and is headquartered in Everett, WA.

VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas.

Beckman Coulter Life Sciences engages in the development, manufacturing, and marketing of products for biomedical testing. It offers air particle counters, cell counters, sizers, and media analyzers, centrifuges, flow cytometers, automated liquid handling solutions, HIAC liquid particle counters, particle size analyzers, and total organic carbon analyzers. The company is headquartered in Indianapolis, IN.

MDS Pharma Services provides contract drug discovery and drug development services for pharmaceutical and biotechnology companies. It provides its clients with early-stage, clinical research and late-stage drug discovery and development services, such as Phase I-IV testing, target discovery and lead optimization. The company is located in Saint-Laurent, Canada.

inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Part of Danaher Corp., AB Sciex LLC is a company that manufactures life science analytical technologies. The company is based in Framingham, MA.

Pure Sunfarms Corp. engages in producing and supplying cannabis. Its products include critical kali mist, purple sun gold, afghan kush, white rhino, hash plant and island honey. The company is headquartered in Delta, Canada.

Nuvelution Pharma, Inc. provides solutions for R&D companies in the pharmaceutical and biotech industries. The firm leverages its knowledge, experience and relationships in the Pharma and Biotech industries to deploy capital in risk-sharing collaborations with companies where product development can be facilitated by both capital and human resources, making this model an essential tool for pharma and biotech companies to bring products to the market. The company was founded by Sanford S. Zweifach and is headquartered in South San Francisco, CA.

Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.